VCs remain thirsty to fund AI coding startups. This one, founded by investor Chamath Palihapitiya, is no exception.
Human-derived organoids improved heart function in pigs with ischemic heart disease, laying the groundwork for their therapeutic potential in humans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results